PreSENTIA – Genetic panels for hereditary breast, uterus, and ovarian cancers.

Know your genes, know your choices!
Avicena Laboratory expands its portfolio and begins the production of genetic panels for hereditary cancers.

The new portfolio of genetic tests, which will help patients get the best possible diagnostic service, which does not require them to visit laboratories abroad, but from now on world-scale tests applied in the most modern medical centers in the world are also available in our country.

“Presentia” – Genetic panels for the detection of mutations that cause hereditary types of breast, ovarian and uterine cancer. The tests represent a revolutionary solution for predicting the risk of cancer as well as helping those patients who have already been diagnosed with the disease to find out the cause of the occurrence of this condition.

PreSENTIA presents a portfolio of hereditary cancer testing panels. Each panel focuses on a particular group of genes that determine your chances of developing cancer in the future. Genetic changes (mutations) in genes that cause cancer can be passed on to children from their parents.

Why PreSENTIA?

• Clinically important genetic mutations are evaluated
• Short processing time of the biological material
• Safe and easy test
• By focusing only on the genetic changes tested, PreSENTIA is accurate and precise.

PreSENTIA panels are used to test for many genetic changes that are responsible for causing hereditary cancers. If patients want to know more about their risk of developing cancer, or if a patient has already been diagnosed with cancer and wants to know if the cancer is inherited, PreSENTIA can help.

PreSENTIA can potentially identify genetic changes that would cause cancer. It has a number of benefits in terms of planning, prognosis and making better decisions about the treatment of the disease:

• Targeted cancer monitoring – recommended screening tests at key time intervals in order to detect cancer early, when treatment is far more effective
• Preventing cancer by taking prophylactic measures
• Obtaining useful information about family members who might carry the same genetic mutation
• Improved disease classification for better clinical disease management
• Drug therapy (chemoprevention), where possible

PreSENTIA Panel 1: BREAST, UTERUS AND OVARIAN CANCER
The PreSENTIA Breast/Gynecologic Cancer Panel tests for multiple gene mutations that could cause breast, ovarian, or uterine cancer in the future. By early detection of these mutations, PreSENTIA helps patients make better and more informed decisions about their health.

Who is this test for?

• Patients who have several family members with cancer
• Family members with early onset cancer
• Family members with rare cancers
• A family member with multiple types of cancer
• A family member diagnosed with a mutation associated with ovarian, uterine, or breast cancer
• Personal history of previous malignant diseases
  Price: 29,500 denars.
  Issuance of results: 2 – 4 WEEKS
  SPECIMEN REQUIRED: BUCCAL SWIPE (mouth swab).

PreSENTIA Panel 2: BREAST CANCER (BRKA1 & BRCA2 MUTATIONS)
An inherited genetic panel that detects BRCA1/BRCA2 mutations that can cause breast and ovarian cancer. By early detection of these mutations, PreSENTIA helps patients make better and more informed decisions about their health.

Who is this test for?

• Several family members with cancer on the same side of the family
• Multiple cancers in the same family member
• Family members with early onset cancer
• Family members with rare cancers
• A family member diagnosed with a germline mutation associated with cancer susceptibility
• History of previous malignant tumors
  Price: 24,900 denars.
  Issuance of results: 2 – 4 WEEKS
  SPECIMEN REQUIRED: BUCCAL SWIPE (mouth swab).